Evidence map›Paper›PMID 39567985›Full record

ArticleHarm reduction journal2024

Experiences of the changing illicit drug supply among racial and ethnic minoritized people in three US states: a qualitative study.

Brendan Saloner, Olivia K Sugarman, Lauren Byrne, Samantha Harris, Molly C Reid, Hridika Shah, Eric Hulsey, Adrienne Hurst, Lindsey Kerins, Dionna King and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Brendan SalonerDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. bsaloner@jhu.edu.
Olivia K SugarmanDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Lauren ByrneDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Samantha HarrisDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Molly C ReidDepartment of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Hridika ShahDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Eric HulseyVital Strategies, New York, NY, USA.
Adrienne HurstVital Strategies, New York, NY, USA.
Lindsey KerinsVital Strategies, New York, NY, USA.
Dionna KingVital Strategies, New York, NY, USA.
Susan ShermanDepartment of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Emily KanerPacific Institute for Research and Evaluation, Berkeley, CA, USA.
Daliah HellerVital Strategies, New York, NY, USA.
Sachini BandaraDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Funding

Bloomberg Philanthropies NA
6 · The paper itself

Abstract

backgroundAmidst a national surge in overdose deaths among racial and ethnic minoritized people and people who use stimulants (cocaine or methamphetamines), our objective was to understand how these groups are adapting to a rapidly changing illicit drug supply.

methodsWe conducted semi-structured interviews with 64 people who use drugs and who self-identified as Black, Hispanic, Multiracial, or other Non-White race in three states (Michigan, New Jersey, and Wisconsin). Transcribed interviews were coded thematically.

resultsMost respondents used stimulants alone or in combination with opioids. Respondents perceived that the drug supply had become more unpredictable and dangerous but differed in their personal perception of risk and their adaptations. For example, respondents had very mixed perceptions of their own risk of being harmed by fentanyl, and differing opinions about whether fentanyl test strips would be useful. Xylazine, a novel adulterant in the opioid drug supply that has received public health and media attention, was not well known within the sample.

conclusionOur study highlights the challenges experienced by minoritized people who use drugs in responding to a changing drug supply, underscoring the limits of public health approaches focused solely on individual behavioral change.

Indexed as

Illicit DrugsAdultAnalgesics, OpioidDrug OverdoseEthnicityFemaleHumansMaleMiddle AgedNew JerseyQualitative ResearchRacial GroupsSubstance-Related DisordersWisconsinYoung AdultAnalgesics, OpioidIllicit DrugsDrug supplyMinoritized populationsOverdose

Identifiers

PMID39567985
PMCPMC11577715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.